The ECG as a tool to determine atrial fibrillation complexity

Heart

Volumn 100, Issue 14, 2014, Pages 1077-1084

  Lankveld, Theo A R ^a   Zeemering, Stef ^b   Crijns, Harry J G M ^a   Schotten, Ulrich ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; IBUTILIDE;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVERSION; CATHETER ABLATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE CONTROL; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ENTROPY; FOLLOW UP; GUIDING CATHETER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; MATHEMATICAL ANALYSIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT PLANNING;

AGING; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84903480256     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305149     Document Type: Article

References (54)

1. Magnani JW, Johnson VM, Sullivan LM, et al. P wave duration and risk of longitudinal atrial fibrillation in persons >/= 60 years old (from the Framingham Heart Study). Am J Cardiol 2011;107:917-21.e1.
2. Zhang BC, Che WL, Li WM, et al. Meta-analysis of P wave character as predictor of atrial fibrillation after coronary artery bypass grafting. Int J Cardiol 2011;152:260-2.
3. Folkeringa RJ, Hartgers J, Tieleman RG, et al. Atrial extrasystoles after exercise predict atrial fibrillation in patients with left ventricular hypertrophy. Heart 2006;92:545-6.
4. Samol A, Masin M, Gellner R, et al. Prevalence of unknown atrial fibrillation in patients with risk factors. Europace 2013;15:657-62.
5. Kaleschke G, Hoffmann B, Drewitz I, et al. Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Europace 2009;11:1362-8.
6. McManus DD, Lee J, Maitas O, et al. A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart Rhythm 2013;10:315-19.
7. Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol 2013;165:193-4.
8. Lowres N, Freedman SB, Redfern J, et al. Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >=65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol. BMJ Open 2012;2. pii: e001355.
9. Reiffel J, Verma A, Halperin JL, et al. Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am Heart J 2014;167:22-7.
10. Langley P, Dewhurst M, Di Marco LY, et al. Accuracy of algorithms for detection of atrial fibrillation from short duration beat interval recordings. Med Eng Phys 2012;34:1441-7.
11. Allessie MA, de Groot NM, Houben RP, et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol 2010;3:606-15.
12. Cuculich PS, Wang Y, Lindsay BD, et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation 2010;122:1364-72.
13. Lee G, Kumar S, Teh A, et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J 2014;35:86-97.
14. Narayan SM, Krummen DE, Shivkumar K, et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012;60:628-36.
15. Holm M, Pehrson S, Ingemansson M, et al. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998;38:69-81. (Pubitemid 28275616)
16. Matsuo S, Lellouche N, Wright M, et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 2009;54:788-95.
17. Guillem MS, Climent AM, Millet J, et al. Noninvasive localization of maximal frequency sites of atrial fibrillation by body surface potential mapping. Circ Arrhythm Electrophysiol 2013;6:294-301.
18. Roithinger FX, SippensGroenewegen A, Karch MR, et al. Organized activation during atrial fibrillation in man: endocardial and electrocardiographic manifestations. J Cardiovasc Electrophysiol 1998;9:451-61.
19. Alcaraz R, Hornero F, Rieta JJ. Assessment of non-invasive time and frequency atrial fibrillation organization markers with unipolar atrial electrograms. Physiol Meas 2011;32:99-114.
20. Schotten U, Maesen B, Zeemering S. The need for standardization of time- and frequency-domain analysis of body surface electrocardiograms for assessment of the atrial fibrillation substrate. Europace 2012;14:1072-5.
21. Choudhary MB, Holmqvist F, Carlson J, et al. Low atrial fibrillatory rate is associated with spontaneous conversion of recent-onset atrial fibrillation. Europace 2013;15:1445-52.
22. Bollmann A, Sonne K, Esperer HD, et al. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG. Cardiovasc Res 1999;44:60-6. (Pubitemid 29431684)
23. Alcaraz R, Hornero F, Rieta JJ. Noninvasive time and frequency predictors of long-standing atrial fibrillation early recurrence after electrical cardioversion. Pacing Clin Electrophysiol 2011;34:1241-50.
24. Holmqvist F, Stridh M, Waktare JE, et al. Atrial fibrillation signal organization predicts sinus rhythm maintenance in patients undergoing cardioversion of atrial fibrillation. Europace 2006;8:559-65. (Pubitemid 44295748)
25. Holmqvist F, Stridh M, Waktare JE, et al. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation. Eur Heart J 2006;27:2201-7. (Pubitemid 44412835)
26. Bollmann A, Husser D, Steinert R, et al. Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2003;14:S162-65. (Pubitemid 37392998)
27. Bollmann A, Kanuru NK, McTeague KK, et al. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998;81:1439-45. (Pubitemid 28283825)
28. Bollmann A, Binias KH, Toepffer I, et al . Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide. Am J Cardiol 2002;90:1011-14. (Pubitemid 35232631)
29. Nault I, Lellouche N, Matsuo S, et al. Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 2009;26:11-19.
30. Cheng Z, Deng H, Cheng K, et al . The amplitude of fibrillatory waves on leads aVF and V1 predicting the recurrence of persistent atrial fibrillation patients who underwent catheter ablation. Ann Noninvasive Electrocardiol 2013;18:352- 8.
31. Petersson R, Sandberg F, Platonov PG, et al. Noninvasive estimation of organization in atrial fibrillation as a predictor of sinus rhythm maintenance. J Electrocardiol 2011;44:171-5.
32. Bollmann A, Tveit A, Husser D, et al. Fibrillatory rate response to candesartan in persistent atrial fibrillation. Europace 2008;10:1138-44.
33. Husser D, Stridh M, Sornmo L, et al. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation. Am J Cardiol 2005;95:526-8. (Pubitemid 40247556)
34. Haissaguerre M, Lim KT, Jacquemet V, et al. Atrial fibrillatory cycle length: computer simulation and potential clinical importance. Europace 2007;9(Suppl 6):vi64-70.
35. Platonov PG, Cygankiewicz I, Stridh M, et al. Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure. Circ Arrhythm Electrophysiol 2012;5:77-83.
36. Koduri H, Ng J, Cokic I, et al. Contribution of fibrosis and the autonomic nervous system to atrial fibrillation electrograms in heart failure. Circ Arrhythm Electrophysiol 2012;5:640-9.
37. Jadidi AS, Cochet H, Shah AJ, et al. Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mapping. J Am Coll Cardiol 2013;62:802- 12.
38. Xi Q, Sahakian AV, Frohlich TG, et al. Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics. Heart Rhythm 2004;1:656-63. (Pubitemid 40028770)
39. Husser D, Cannom DS, Bhandari AK, et al. Electrocardiographic characteristics of fibrillatory waves in new-onset atrial fi brillation. Europace 2007;9:638-42. (Pubitemid 47263795)
40. Meo M, Zarzoso V, Meste O, et al. Non-invasive prediction of catheter ablation outcome in persistent atrial fibrillation by exploiting the spatial diversity of surface ECG. Conf Proc IEEE Eng Med Biol Soc 2011;2011:5531-4.
41. Meo M, Zarzoso V, Meste O, et al. Spatial variability of the 12-lead surface ECG as a tool for noninvasive prediction of catheter ablation outcome in persistent atrial fibrillation. IEEE Trans Biomed Eng 2013;60:20-7.
42. Bollmann A, Husser D, Mainardi L, et al. Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. Europace 2006;8:911-26. (Pubitemid 44636881)
43. Ihara Z, van Oosterom A, Jacquemet V, et al. Adaptation of the standard 12-lead electrocardiogram system dedicated to the analysis of atrial fibrillation. J Electrocardiol 2007;40:68.e1-8.
44. Husser D, Stridh M, Sornmo L, et al. Electroatriography - time-frequency analysis of atrial fibrillation from modified 12-lead ECG configurations for improved diagnosis and therapy. Med Hypotheses 2007;68:568-73. (Pubitemid 46037973)
45. Binkley PF, Bush CA, Fleishman BL, et al. In vivo validation of the origin of the esophageal electrocardiogram. J Am Coll Cardiol 1986;7:813-18. (Pubitemid 16107126)
46. Ramanathan C, Ghanem RN, Jia P, et al. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat Med 2004;10:422-8. (Pubitemid 38508523)
47. Haissaguerre M, Hocini M, Shah AJ, et al. Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report. J Cardiovasc Electrophysiol 2013;24:711-17.
48. Guillem MS, Climent AM, Castells F, et al. Noninvasive mapping of human atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:507-13.
49. SippensGroenewegen A, Natale A, Marrouche NF, et al. Potential role of body surface ECG mapping for localization of atrial fi brillation trigger sites. J Electrocardiol 2004;37:47-52.
50. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
51. Kirchhof P, Breithardt G, Aliot E, et al. Personalized management of atrial fibrillation: proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 2013;15:1540-56.
52. Alcaraz R, Sandberg F, Sornmo L, et al. Classification of paroxysmal and persistent atrial fibrillation in ambulatory ECG recordings. IEEE Trans Biomed Eng 2011;58:1441-9.
53. Uldry L, Van Zaen J, Prudat Y, et al. Measures of spatiotemporal organization differentiate persistent from long-standing atrial fibrillation. Europace 2012;14:1125-31.
54. Camm AJ, Breithardt G, Crijns H, et al. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol 2011;58:493-501.